These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9609575)

  • 1. When does estrogen replacement therapy improve sleep quality?
    Polo-Kantola P; Erkkola R; Helenius H; Irjala K; Polo O
    Am J Obstet Gynecol; 1998 May; 178(5):1002-9. PubMed ID: 9609575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life.
    Toffol E; Kalleinen N; Haukka J; Vakkuri O; Partonen T; Polo-Kantola P
    Menopause; 2014 May; 21(5):493-500. PubMed ID: 24065140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial.
    Tansupswatdikul P; Chaikittisilpa S; Jaimchariyatam N; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    Climacteric; 2015 Apr; 18(2):198-204. PubMed ID: 25242569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women.
    Polo-Kantola P; Erkkola R; Irjala K; Pullinen S; Virtanen I; Polo O
    Fertil Steril; 1999 May; 71(5):873-80. PubMed ID: 10231049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasomotor and depression symptoms may be associated with different sleep disturbance patterns in postmenopausal women.
    Vousoura E; Spyropoulou AC; Koundi KL; Tzavara C; Verdeli H; Paparrigopoulos T; Augoulea A; Lambrinoudaki I; Zervas IM
    Menopause; 2015 Oct; 22(10):1053-7. PubMed ID: 25783470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
    Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
    J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
    Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
    Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens.
    Odmark IS; Bäckström T; Jonsson B; Bixo M
    Climacteric; 2004 Mar; 7(1):92-102. PubMed ID: 15259288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women.
    Ruan X; Cui Y; Du J; Jin F; Mueck AO
    J Psychosom Obstet Gynaecol; 2017 Sep; 38(3):161-169. PubMed ID: 27766930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of symptoms of climacteric syndrome, depression and insomnia on self-rated work ability in peri- and post-menopausal women in non-manual employment.
    Humeniuk E; Bojar I; Gujski M; Raczkiewicz D
    Ann Agric Environ Med; 2019 Dec; 26(4):600-605. PubMed ID: 31885234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia.
    Zervas IM; Lambrinoudaki I; Spyropoulou AC; Koundi KL; Voussoura E; Tzavara C; Verdeli H; Aravantinos L; Creatsa M; Paparrigopoulos T
    Menopause; 2009; 16(4):837-42. PubMed ID: 19169170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints.
    Skarsgård C; E Berg G; Ekblad S; Wiklund I; Hammar ML
    Maturitas; 2000 Aug; 36(2):123-30. PubMed ID: 11006499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.